We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.
Members of the Oxford and Thames Valley MDS Patient Support Group, which provides support to those affected by Myelodysplastic Syndromes, visited the MRC Weatherall Institute of Molecular Medicine (WIMM) on Friday 29 September.
Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.
